ArticleClinical & translational immunology2017
Inhibition of IL-17A by secukinumab shows no evidence of increased
Michael Kammüller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it